Lucira Health, Inc. (LHDX) News
Filter LHDX News Items
LHDX News Results
|Loading, please wait...|
LHDX News Highlights
- LHDX's 30 day story count now stands at 9.
- Over the past 5 days, the trend for LHDX's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- DRUG, FOLD and LAB are the most mentioned tickers in articles about LHDX.
Latest LHDX News From Around the Web
Below are the latest news stories about LUCIRA HEALTH INC that investors may wish to consider to help them evaluate LHDX as an investment opportunity.
First Solar (FSLR) stock rose on Friday after the solar power company got an upgrade and increased price target from UBS.
We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!
Lucira Health (LHDX) stock is falling on Friday after the company's shares have seen extreme volatility throughout the week.
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!
We're starting off Monday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!
Cyren (CYRN) stock is falling on Monday as the cybersecurity company's shares continue to experience volatility following news last week.
Lucira Health (LHDX) stock is rocketing higher on Monday thanks to an update from the FDA on its at-home Covid-19 and flu tests.
ObsEva (OBSV) stock is bouncing back on Monday after the company's stock underwent a major dip during the prior day of trading.
Tegna (TGNA) stock is falling on Monday following news that a buyout deal for the company is being put on hold by the FCC.
Friday, the FDA issued an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test to differentiate and detect influenza A and B. Lucira Health Inc's (NASDAQ: LHDX) COVID-19 & Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes. The single-use test can be purchased without a prescription and performed entirely at home using nasal swab samples self-collected by individuals ages 14 y